ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $707 | -73.2% | 10,000 | -50.0% | 0.00% | -100.0% |
| Q3 2023 | $2,636 | -74.2% | 20,000 | 0.0% | 0.00% | -66.7% |
| Q2 2023 | $10,200 | -19.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $12,600 | -2.9% | 20,000 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $12,982 | -61.8% | 20,000 | 0.0% | 0.00% | -66.7% |
| Q3 2022 | $34,000 | +3300.0% | 20,000 | +9900.0% | 0.01% | +1100.0% |
| Q3 2018 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 15,151,516 | $49,697,000 | 12.67% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 9,642,760 | $31,628,000 | 5.74% |
| MILLER VALUE PARTNERS, LLC | 12,619,730 | $41,393,000 | 1.84% |
| MAGNOLIA CAPITAL ADVISORS LLC | 90,585 | $297,000 | 0.38% |
| Sargent Investment Group, LLC | 232,025 | $759,000 | 0.28% |
| Old West Investment Management, LLC | 210,583 | $690,000 | 0.20% |
| Virtus ETF Advisers LLC | 112,619 | $369,000 | 0.18% |
| tru Independence LLC | 213,712 | $701,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 180,297 | $591,000 | 0.08% |
| Golden State Wealth Management, LLC | 90,585 | $297,000 | 0.08% |